<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK24676" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK24676/" /><meta name="ncbi_pagename" content="Koolen-de Vries Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Koolen-de Vries Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Koolen-de Vries Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/06/13" /><meta name="citation_author" content="David A Koolen" /><meta name="citation_author" content="Angela Morgan" /><meta name="citation_author" content="Bert BA de Vries" /><meta name="citation_pmid" content="20301783" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK24676/" /><meta name="citation_keywords" content="KdVS" /><meta name="citation_keywords" content="KdVS" /><meta name="citation_keywords" content="KAT8 regulatory NSL complex subunit 1" /><meta name="citation_keywords" content="KANSL1" /><meta name="citation_keywords" content="Koolen-de Vries Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Koolen-de Vries Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="David A Koolen" /><meta name="DC.Contributor" content="Angela Morgan" /><meta name="DC.Contributor" content="Bert BA de Vries" /><meta name="DC.Date" content="2019/06/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK24676/" /><meta name="description" content="Koolen-de Vries syndrome (KdVS) is characterized by developmental delay / intellectual disability, neonatal/childhood hypotonia, dysmorphisms, congenital malformations, and behavioral features. Psychomotor developmental delay is noted in all individuals from an early age. The majority of individuals with KdVS function in the mild-to-moderate range of intellectual disability. Other findings include speech and language delay (100%), epilepsy (~33%), congenital heart defects (25%-50%), renal and urologic anomalies (25%-50%), and cryptorchidism (71% of males). Behavior in most is described as friendly, amiable, and cooperative." /><meta name="og:title" content="Koolen-de Vries Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Koolen-de Vries syndrome (KdVS) is characterized by developmental delay / intellectual disability, neonatal/childhood hypotonia, dysmorphisms, congenital malformations, and behavioral features. Psychomotor developmental delay is noted in all individuals from an early age. The majority of individuals with KdVS function in the mild-to-moderate range of intellectual disability. Other findings include speech and language delay (100%), epilepsy (~33%), congenital heart defects (25%-50%), renal and urologic anomalies (25%-50%), and cryptorchidism (71% of males). Behavior in most is described as friendly, amiable, and cooperative." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK24676/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mdel17q21_31/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK24676/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BC17EE0414EC1000000000A1C03E3.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK24676_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK24676_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kleefstra/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/krabbe/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK24676_"><span class="title" itemprop="name">Koolen-de Vries Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: KdVS</div><p class="contrib-group"><span itemprop="author">David A Koolen</span>, MD, PhD, <span itemprop="author">Angela Morgan</span>, Prof, PhD, and <span itemprop="author">Bert BA de Vries</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK24676_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK24676_ai__"><div class="contrib half_rhythm"><span itemprop="author">David A Koolen</span>, MD, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Nijmegen Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@nelook.divad" class="oemail">ln.cmuduobdar@nelook.divad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Angela Morgan</span>, Prof, PhD<div class="affiliation small">Murdoch Children's Research Institute<br />Victoria, Australia</div><div class="affiliation small">Department of Audiology and Speech Pathology<br />University of Melbourne<br />Melbourne, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.ude.ircm@nagrom.alegna" class="oemail">ua.ude.ircm@nagrom.alegna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bert BA de Vries</span>, MD, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Nijmegen Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@seirved.treb" class="oemail">ln.cmuduobdar@seirved.treb</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ln.ncmu.neg@seirved.b" class="oemail">ln.ncmu.neg@seirved.b</a><div></div></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 26, 2010</span>; Last Update: <span itemprop="dateModified">June 13, 2019</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mdel17q21_31.Summary" itemprop="description"><h2 id="_mdel17q21_31_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Koolen-de Vries syndrome (KdVS) is characterized by developmental delay / intellectual disability, neonatal/childhood hypotonia, dysmorphisms, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations, and behavioral features. Psychomotor developmental delay is noted in all individuals from an early age. The majority of individuals with KdVS function in the mild-to-moderate range of intellectual disability. Other findings include speech and language delay (100%), epilepsy (~33%), congenital heart defects (25%-50%), renal and urologic anomalies (25%-50%), and cryptorchidism (71% of males). Behavior in most is described as friendly, amiable, and cooperative.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Koolen-de Vries syndrome is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has either a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> 500- to 650-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17q21.31 that includes <i>KANSL1</i> or a heterozygous intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KANSL1</i>. Note: The 17q21.31 deletion cannot be identified by analysis of G-banded chromosomes or other <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> banding techniques.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physiotherapy for gross and fine motor delays; speech therapy to support early feeding challenges and communication development; educational programs directed to specific disabilities identified. Routine treatment of: vision issues / strabismus; hearing loss; cardiac, renal, and urologic problems; epilepsy; scoliosis, hip dislocation, and positional deformities of the feet; multiple nevi.</p><p><i>Surveillance:</i> Routine ophthalmologic examinations for hypermetropia and strabismus; monitoring for progressive spine deformities; routine monitoring for other medication complications depending on the organ system involved.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Koolen-de Vries syndrome, caused by a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 17q21.31 or a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KANSL1</i>, is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner; to date almost all cases result from a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> deletion or <i>KANSL1</i> pathogenic variant. Thus, most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family). The <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> for future pregnancies is low (probably &#x0003c;1%) but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in one of the parents. Prenatal testing is technically feasible, but the likelihood of recurrence in families who have had an affected child is low.</p></div></div><div id="mdel17q21_31.Diagnosis"><h2 id="_mdel17q21_31_Diagnosis_">Diagnosis</h2><div id="mdel17q21_31.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Koolen-de Vries syndrome (KdVS) <b>should be suspected</b> in individuals presenting with mild-to-moderate developmental delay or intellectual disability in which speech and language development is particularly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, in combination with additional clinical findings.</p><p><b>Additional clinical findings</b></p><ul><li class="half_rhythm"><div>Neonatal/childhood hypotonia and feeding difficulties</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Dysmorphic facial features (see <a href="#mdel17q21_31.Clinical_Description">Clinical Description</a> and <a class="figpopup" href="/books/NBK24676/figure/mdel17q21_31.F1/?report=objectonly" target="object" rid-figpopup="figmdel17q2131F1" rid-ob="figobmdel17q2131F1">Figure 1</a>)</div></li><li class="half_rhythm"><div>Hypermetropia</div></li><li class="half_rhythm"><div>Congenital heart anomalies</div></li><li class="half_rhythm"><div>Congenital renal/urologic anomalies</div></li><li class="half_rhythm"><div>Hypermobility of the joints and/or joint dislocation/dysplasia</div></li><li class="half_rhythm"><div>Deformities of the spine and/or feet</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmdel17q2131F1" co-legend-rid="figlgndmdel17q2131F1"><a href="/books/NBK24676/figure/mdel17q21_31.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmdel17q2131F1" rid-ob="figobmdel17q2131F1"><img class="small-thumb" src="/books/NBK24676/bin/mdel17q21_31-Image001.gif" src-large="/books/NBK24676/bin/mdel17q21_31-Image001.jpg" alt="Figure 1. . Photographs of eight individuals with a 17q21." /></a><div class="icnblk_cntnt" id="figlgndmdel17q2131F1"><h4 id="mdel17q21_31.F1"><a href="/books/NBK24676/figure/mdel17q21_31.F1/?report=objectonly" target="object" rid-ob="figobmdel17q2131F1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Photographs of eight individuals with a 17q21.31 deletion </p></div></div></div><div id="mdel17q21_31.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Koolen-de Vries syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical <a href="#mdel17q21_31.Suggestive_Findings">clinical findings</a> and detection of any of the following (see <a class="figpopup" href="/books/NBK24676/table/mdel17q21_31.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmdel17q2131Tmoleculargenetictesting" rid-ob="figobmdel17q2131Tmoleculargenetictesting">Table 1</a>):</p><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17q21.31 that includes <i>KANSL1</i> (~95% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2006.999">Koolen et al 2006</a>, <a class="bk_pop" href="#mdel17q21_31.REF.sharp.2006.1038">Sharp et al 2006</a>, <a class="bk_pop" href="#mdel17q21_31.REF.shawsmith.2006.1032">Shaw-Smith et al 2006</a>]. The 17q21.31 deletion is typically 500- to 650-kb in size (hg19: chr17:43,700,000-44,250,000) and is flanked by segmental duplications.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KANSL1</i> (~5% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2012.636">Zollino et al 2012</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2015.804">Zollino et al 2015</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>].</div></li><li class="half_rhythm"><div>Haploinsufficiency of <i>KANSL1</i> due to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangements [<a class="bk_pop" href="#mdel17q21_31.REF.morenoigoa.2015.68">Moreno-Igoa et al 2015</a>].</div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA)</b>, <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p><b>Chromosomal microarray analysis (CMA)</b> uses oligonucleotide or SNP arrays to detect genome-wide large deletions/duplications (including <i>KANSL1</i>) that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. CMA is recommended first because deletions are identified in ~95% of probands (see <a href="https://www.ncbi.nlm.nih.gov/books/NBK458647/table/satb2-dis.T.molecular_genetic_testing_us/?report=objectonly" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Table 1</a>). The ability to determine the size of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> depends on the type of microarray used and the density of probes in the 17q21.31 region.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> does not identify the cause of the individual&#x02019;s features, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing, which requires that the clinician to determine which gene(s) are likely involved, or <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing may be considered. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of KdVS is broad, individuals with the distinctive findings described in <a href="#mdel17q21_31.Suggestive_Findings">Suggestive Findings</a> may be diagnosed using gene-targeted testing (see <a href="#mdel17q21_31.Option_1">Option 1</a>), whereas those in whom the diagnosis of KdVS has not been considered are more likely to be diagnosed using other genomic testing (see <a href="#mdel17q21_31.Option_2">Option 2</a>).</p><div id="mdel17q21_31.Option_1"><h4>Option 1</h4><p>If a <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is not identified on CMA, testing options include the following:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>KANSL1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications that may have been missed on CMA.</div></li><li class="half_rhythm"><div class="half_rhythm">An <b>intellectual disability <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>KANSL1</i> and other genes of interest (see <a href="#mdel17q21_31.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK24676/table/mdel17q21_31.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figmdel17q2131Tmoleculargenetictesting" rid-ob="figobmdel17q2131Tmoleculargenetictesting">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="mdel17q21_31.Option_2"><h4>Option 2</h4><p>When the diagnosis of KdVS is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p></div><div id="mdel17q21_31.Further_Testing_to_Consider"><h4>Further Testing to Consider</h4><p>If a 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is not identified on CMA and an intragenic <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified on either a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (genomic sequencing and <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>), additional options for testing include <b><a class="def" href="/books/n/gene/glossary/def-item/karyotype/">karyotype</a>.</b> A <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with a 17q21.31 breakpoint that disrupted <i>KANSL1</i> has been observed in one case report [<a class="bk_pop" href="#mdel17q21_31.REF.morenoigoa.2015.68">Moreno-Igoa et al 2015</a>].</p><div id="mdel17q21_31.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Koolen-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>KANSL1</i></td><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CMA&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~95%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%</td></tr><tr><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 8</td></tr><tr><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Karyotype (to detect structural variants)</td><td headers="hd_h_mdel17q21_31.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>9</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mdel17q21_31.TF.1.1"><p class="no_margin">See <a href="/books/NBK24676/#mdel17q21_31.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="mdel17q21_31.TF.1.2"><p class="no_margin">See <a href="#mdel17q21_31.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="mdel17q21_31.TF.1.3"><p class="no_margin">The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified by a genome-wide CMA screen for deletions/duplications that includes probe coverage of <i>KANSL1</i>. The ability to size the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> depends on the type of microarray used and the density of probes in the 17q21.31 region. It is too early to ascertain the frequency of the 17q21.31 microdeletion and a <i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Given the fact that the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> involved is flanked by segmental duplications, predisposing the locus to undergo deletion, it is likely that the recurrent microdeletion occurs more frequently.</p></div></dd><dt>4. </dt><dd><div id="mdel17q21_31.TF.1.4"><p class="no_margin">To date, testing in all unaffected parents from whom the deleted <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17 originated has shown a 900-kb inversion involving chromosome 17q21.31. The frequency of this inversion (also referred to as the H2 lineage) in these parents is significantly greater than the ~20% frequency of the inversion found in the European population as a whole [<a class="bk_pop" href="#mdel17q21_31.REF.stefansson.2005.129">Stefansson et al 2005</a>] (p&#x0003c;10-5, Pearson's Chi square test) [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2008.710">Koolen et al 2008</a>]. Testing for the inversion is not routinely indicated (see <a href="#mdel17q21_31.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>5. </dt><dd><div id="mdel17q21_31.TF.1.5"><p class="no_margin">CMA testing is appropriate to define breakpoints of large deletions; however, intragenic deletions in <i>KANSL1</i> may not be detected by this method. Note: To date, all <i>KANSL1</i> intragenic deletions reported have been identified through CMA analysis.</p></div></dd><dt>6. </dt><dd><div id="mdel17q21_31.TF.1.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="mdel17q21_31.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="mdel17q21_31.TF.1.8"><p class="no_margin">Gene-targeted methods will detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> up to whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions; however, breakpoints of large deletions and/or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of adjacent genes may not be determined. <i>KANSL1</i> gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> could be considered if CMA and <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> are not diagnostic, as smaller, atypical deletions encompassing part of <i>KANSL1</i> have been reported [<a class="bk_pop" href="#mdel17q21_31.REF.cooper.2011.838">Cooper et al 2011</a>, <a class="bk_pop" href="#mdel17q21_31.REF.dubourg.2011.144">Dubourg et al 2011</a>, <a class="bk_pop" href="#mdel17q21_31.REF.kitsioutzeli.2012.319">Kitsiou-Tzeli et al 2012</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>].</p></div></dd><dt>9. </dt><dd><div id="mdel17q21_31.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#mdel17q21_31.REF.morenoigoa.2015.68">Moreno-Igoa et al [2015]</a></p></div></dd></dl></div></div></div></div></div></div><div id="mdel17q21_31.Clinical_Characteristics"><h2 id="_mdel17q21_31_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mdel17q21_31.Clinical_Description"><h3>Clinical Description</h3><p>Koolen-de Vries syndrome (KdVS) has a clinically recognizable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that includes neonatal/childhood hypotonia, developmental delay / intellectual disability, dysmorphisms (<a class="figpopup" href="/books/NBK24676/figure/mdel17q21_31.F1/?report=objectonly" target="object" rid-figpopup="figmdel17q2131F1" rid-ob="figobmdel17q2131F1">Figure 1</a>), speech and language delays, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations, and behavioral features (<a class="figpopup" href="/books/NBK24676/table/mdel17q21_31.T.features_of_koolende_vrie/?report=objectonly" target="object" rid-figpopup="figmdel17q2131Tfeaturesofkoolendevrie" rid-ob="figobmdel17q2131Tfeaturesofkoolendevrie">Table 2</a>). Males and females are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> equally.</p><div id="mdel17q21_31.T.features_of_koolende_vrie" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Features of Koolen-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.features_of_koolende_vrie/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.features_of_koolende_vrie_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Frequency</th><th id="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Feature</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Very common</b><br /><b>(&#x0003e;75% of</b><br /><b>individuals)</b></td><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Distinctive facial features (see <b>Dysmorphic craniofacial features</b> following table)</div></li><li class="half_rhythm"><div>Hypotonia (neonatal/childhood)</div></li><li class="half_rhythm"><div>Developmental delay / intellectual disability</div></li><li class="half_rhythm"><div>Speech &#x00026; language delay</div></li><li class="half_rhythm"><div>Friendly/amiable disposition</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Common</b><br /><b>(50%-75%)</b></td><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Structural brain anomalies</div><ul><li class="half_rhythm"><div>Ventriculomegaly</div></li><li class="half_rhythm"><div>Aplasia/hypoplasia of corpus callosum</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Arnold-Chiari type I malformation</div></li><li class="half_rhythm"><div>Intraventricular hemorrhage</div></li></ul></li><li class="half_rhythm"><div>Joint hypermobility &#x00026;/or joint dislocation/dysplasia</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Less common</b><br /><b>(25%-50%)</b></td><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Visual impairment</div><ul><li class="half_rhythm"><div>Hypermetropia</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Congenital cataract</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul></li><li class="half_rhythm"><div>Abnormality of the heart</div><ul><li class="half_rhythm"><div>Ventricular septal defect</div></li><li class="half_rhythm"><div>Atria septal defect</div></li><li class="half_rhythm"><div>Bicuspid aortic valve</div></li><li class="half_rhythm"><div>Cardiomyopathy</div></li><li class="half_rhythm"><div>Aortic dilatation</div></li></ul></li><li class="half_rhythm"><div>Renal &#x00026; urogenital anomalies</div><ul><li class="half_rhythm"><div>Cryptorchidism</div></li><li class="half_rhythm"><div>Hydronephrosis / vesicoureteral reflux</div></li><li class="half_rhythm"><div>Renal duplication</div></li><li class="half_rhythm"><div>Fetal pyelectasis</div></li></ul></li><li class="half_rhythm"><div>Hypospadias</div></li><li class="half_rhythm"><div>Feeding difficulties</div></li><li class="half_rhythm"><div>Long fingers</div></li><li class="half_rhythm"><div><i>Pes planus</i> / <i>pes cavus</i> / calcaneovalgus deformity</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Occasional</b><br /><b>(10%-25%)</b></td><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Anxiety</div></li><li class="half_rhythm"><div>Attention-deficit/hyperactivity disorder</div></li><li class="half_rhythm"><div>Hearing impairment</div></li><li class="half_rhythm"><div>Scoliosis/kyphosis</div></li><li class="half_rhythm"><div>Tracheo-/laryngeomalacia</div></li><li class="half_rhythm"><div>Pectus excavatum/carinatum</div></li><li class="half_rhythm"><div>Slender build</div></li><li class="half_rhythm"><div>Multiple nevi</div></li><li class="half_rhythm"><div>Fair hair</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Infrequent</b><br /><b>(&#x0003c;10%)</b></td><td headers="hd_h_mdel17q21_31.T.features_of_koolende_vrie_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Autistic behavior</div></li><li class="half_rhythm"><div>Craniosynostosis</div></li><li class="half_rhythm"><div>Sacral dimple</div></li><li class="half_rhythm"><div>Spondylolisthesis</div></li><li class="half_rhythm"><div>Dural ectasia</div></li><li class="half_rhythm"><div>Spina bifida</div></li><li class="half_rhythm"><div>Pineal cyst</div></li><li class="half_rhythm"><div>Cervical spinal canal stenosis</div></li><li class="half_rhythm"><div>Recurrent urinary tract infections</div></li><li class="half_rhythm"><div>Recurrent respiratory infections</div></li><li class="half_rhythm"><div>Recurrent otitis media</div></li><li class="half_rhythm"><div>Eczema</div></li><li class="half_rhythm"><div>Hypopigmentation of the skin / vitiligo</div></li><li class="half_rhythm"><div>Alopecia</div></li><li class="half_rhythm"><div>Caf&#x000e9; au lait spots</div></li><li class="half_rhythm"><div>Ichthyosis/hyperkeratosis</div></li><li class="half_rhythm"><div>Growth hormone deficiency</div></li><li class="half_rhythm"><div>Hypothyroidism</div></li><li class="half_rhythm"><div>Precocious puberty</div></li><li class="half_rhythm"><div>Primary adrenal insufficiency</div></li><li class="half_rhythm"><div>Melanoma</div></li><li class="half_rhythm"><div>Testicular neoplasm</div></li><li class="half_rhythm"><div>Hemangioma</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Clinical information based on data entered in the <a href="http://humandiseasegenes.nl/hdgw/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HDG website Series</a></p></div></dd></dl></div></div></div><p><b>Dysmorphic craniofacial features</b> that may suggest KdVS:</p><ul><li class="half_rhythm"><div>Upslanted palpebral fissure</div></li><li class="half_rhythm"><div>Blepharophimosis</div></li><li class="half_rhythm"><div>Epicanthus</div></li><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Pear-shaped nose</div></li><li class="half_rhythm"><div>Bulbous nose</div></li><li class="half_rhythm"><div>Large/protruding ears</div></li></ul><p>The nose can have a high nasal bridge, a broad nasal root, long columella, and underdeveloped and/or thick alae nasi. The facial characteristics change with age. In infancy the facial gestalt is mostly characterized by hypotonia with an open mouth appearance. With increasing age there is usually elongation of the face and broadening of the chin, and the "tubular'' or "pear'' shape form of the nose may become more apparent.</p><p><b>Hypotonia</b> with poor sucking and slow feeding can be evident in the neonatal period and during childhood. Feeding difficulties may require hospitalization and/or nasogastric tube feeding in some neonates. Beyond infancy and into the preschool years, many children experience problems chewing difficult, lumpy, or solid textures [<a class="bk_pop" href="#mdel17q21_31.REF.morgan.2018a.75">Morgan et al 2018a</a>].</p><p><b>Psychomotor developmental delay</b> is noted in all individuals from an early age. The level of developmental delay varies significantly. The majority of individuals with KdVS function in the mild-to-moderate range of intellectual disability.</p><ul><li class="half_rhythm"><div><b>Communication disorder</b> is a core feature of KdVS with a common speech and language <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> seen. This includes an overriding "double hit" of oral hypotonia and apraxia in infancy and preschool, associated with severely delayed speech development [<a class="bk_pop" href="#mdel17q21_31.REF.morgan.2018a.75">Morgan et al 2018a</a>].</div><ul><li class="half_rhythm"><div>First words occur between ages 2.5 and 3.5 years on average.</div></li><li class="half_rhythm"><div>Childhood apraxia of speech (CAS) is common in these preschool years, and speech development is effortful even when supported with intensive therapy.</div></li><li class="half_rhythm"><div>Augmentative (e.g., sign language) or alternative (e.g., communication devices) communication may alleviate frustration for the child and promote communication development.</div></li><li class="half_rhythm"><div>Overall, however, speech prognosis is positive, with CAS improving markedly around age eight to 12 years. At this time, the dysarthric element of speech is more apparent with a slow rate and monotone presentation.</div></li></ul></li><li class="half_rhythm"><div>Stuttering is present in a handful of cases (17%), and has been noted in adolescence only.</div></li><li class="half_rhythm"><div>Receptive and expressive language abilities are typically commensurate (79%), both being severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative to peers.</div></li><li class="half_rhythm"><div>Children are reported as sociable with a desire to communicate; in some individuals (36%) social skill impairments appear with increasing age and increasing social demands.</div></li></ul><p><b>Epilepsy,</b> including generalized seizures and unilateral clonic seizures, is noted in approximately 33% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. The epilepsy phenotypic spectrum in KdVS is broad; however, most individuals have focal seizures, with some having a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> resembling the self-limited focal epilepsies of childhood [<a class="bk_pop" href="#mdel17q21_31.REF.myers.2017.1085">Myers et al 2017</a>].</p><ul><li class="half_rhythm"><div>The typical epilepsy <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of KdVS involves childhood-onset focal seizures that are prolonged and have prominent autonomic features.</div></li><li class="half_rhythm"><div>Multifocal epileptiform discharges are the typical EEG pattern.</div></li><li class="half_rhythm"><div>Structural brain abnormalities may be universal, including signs of abnormal neuroblast migration and abnormal axonal guidance (see <a class="figpopup" href="/books/NBK24676/table/mdel17q21_31.T.features_of_koolende_vrie/?report=objectonly" target="object" rid-figpopup="figmdel17q2131Tfeaturesofkoolendevrie" rid-ob="figobmdel17q2131Tfeaturesofkoolendevrie">Table 2</a>).</div></li></ul><p><b>Other common findings</b> (see <a class="figpopup" href="/books/NBK24676/table/mdel17q21_31.T.features_of_koolende_vrie/?report=objectonly" target="object" rid-figpopup="figmdel17q2131Tfeaturesofkoolendevrie" rid-ob="figobmdel17q2131Tfeaturesofkoolendevrie">Table 2</a>) include dental anomalies, slender long fingers, persistence of the fetal fingertip pads, hypoplasia of the hand muscles, slender lower limbs, joint hypermobility, hip dislocation, and positional deformities of the feet. In addition, multiple nevi, other pigmentary skin abnormalities, and hair abnormalities have been reported [<a class="bk_pop" href="#mdel17q21_31.REF.wright.2011.15">Wright et al 2011</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2015.804">Zollino et al 2015</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>].</p><ul><li class="half_rhythm"><div><b>Congenital heart defects</b> mainly include septal heart defects; however, cardiac valve disease, aortic root dilatation, and pulmonary stenosis have also been described.</div></li><li class="half_rhythm"><div><b>Renal and urologic anomalies</b> include vesicoureteral reflux, hydronephrosis, pyelectasis, and duplex renal system. Cryptorchidism has been reported in the majority of males.</div></li><li class="half_rhythm"><div><b>Scoliosis</b> is the most commonly observed spine anomaly; lordosis and kyphosis have also been reported and sometimes require surgery [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2008.710">Koolen et al 2008</a>, <a class="bk_pop" href="#mdel17q21_31.REF.tan.2009.480">Tan et al 2009</a>].</div></li><li class="half_rhythm"><div><b>Behavior.</b> In the vast majority of individuals, behavior is described as friendly, amiable, and cooperative, with or without frequent laughing. However, behavior problems, including attention-deficit/hyperactivity disorder, have been reported [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2008.710">Koolen et al 2008</a>, <a class="bk_pop" href="#mdel17q21_31.REF.tan.2009.480">Tan et al 2009</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>].</div></li></ul><p><b>Growth.</b> Short stature is not one of the most common clinical features of the syndrome. However, <a class="bk_pop" href="#mdel17q21_31.REF.el_chehadehdjebbar.2011.369">El Chehadeh-Djebbar et al [2011]</a> reported on a child with a 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, short stature (-4 SD), complete growth hormone deficiency, and gonadotropic deficiency [<a class="bk_pop" href="#mdel17q21_31.REF.el_chehadehdjebbar.2011.369">El Chehadeh-Djebbar et al 2011</a>]. Brain MRI showed partial pituitary stalk interruption, expanding the phenotypic spectrum of the syndrome.</p><p><b>Life span.</b> Longitudinal data are insufficient to determine life expectancy, although survival into adulthood is typical.</p></div><div id="mdel17q21_31.GenotypePhenotype_Correlati"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations in KdVS have not been shown. Notably, the clinical features of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with atypical deletions and those with pathogenic variants in <i>KANSL1</i> are in keeping with the phenotype seen in individuals with a classic 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#mdel17q21_31.REF.zollino.2015.804">Zollino et al 2015</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>].</p></div><div id="mdel17q21_31.Penetrance"><h3>Penetrance</h3><p>Penetrance is 100%: clinical features of KdVS are apparent in all individuals with a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of or a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>KANSL1</i>, although the extent and severity of clinical findings vary among individuals.</p></div><div id="mdel17q21_31.Nomenclature"><h3>Nomenclature</h3><p>The disorder was first recognized following microarray analysis among large cohorts of unselected individuals with intellectual disability [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2006.999">Koolen et al 2006</a>, <a class="bk_pop" href="#mdel17q21_31.REF.sharp.2006.1038">Sharp et al 2006</a>, <a class="bk_pop" href="#mdel17q21_31.REF.shawsmith.2006.1032">Shaw-Smith et al 2006</a>]. The identification of individuals with a similar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2012.636">Zollino et al 2012</a>] led OMIM to assign the name "Koolen-de Vries syndrome" to the condition.</p></div><div id="mdel17q21_31.Prevalence"><h3>Prevalence</h3><p>The prevalence of Koolen-de Vries syndrome is unknown. The authors estimate the prevalence of the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 1:55,000 individuals [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>]. The prevalence of individuals with a pathogenic sequence variant in <i>KANSL1</i> cannot be determined with precision owing to the limited number of such <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals identified thus far. Preliminary data suggest that pathogenic <i>KANSL1</i> sequence variants may be as frequent as deletions, but more studies are needed to determine an unbiased prevalence.</p><p>Koolen-de Vries syndrome occurs with equal frequency in males and females [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2008.710">Koolen et al 2008</a>].</p></div></div><div id="mdel17q21_31.Genetically_Related_Allelic"><h2 id="_mdel17q21_31_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the genes located within the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> or with pathogenic variants in <i>KANSL1</i>.</p><p><b>Duplication of 17q21.31</b> (OMIM <a href="https://omim.org/entry/613533" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613533</a>). Persons with a reciprocal <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of the region deleted in Koolen-de Vries syndrome differ phenotypically from those with the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. The reciprocal duplication has been found in a female with severe psychomotor developmental delay, microcephaly, facial dysmorphisms, abnormal digits, and hirsutism [<a class="bk_pop" href="#mdel17q21_31.REF.kirchhoff.2007.256">Kirchhoff et al 2007</a>] and in four individuals with mild psychomotor retardation and behavior problems [<a class="bk_pop" href="#mdel17q21_31.REF.grisart.2009.524">Grisart et al 2009</a>].</p><p><b><i>MAPT.</i></b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variants in <i>MAPT</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding microtubule-associated protein tau, have been identified in individuals diagnosed with frontotemporal dementia with parkinsonism-17. These variants result in pathogenic deposits of hyperphosphorylated tau. This is in contrast to the <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>MAPT</i> in Koolen-de Vries syndrome due to a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 17q21.31 that includes <i>KANSL1</i> and <i>MAPT</i>. Therefore, individuals who have the 17q21.31 deletion are not at an increased risk for FTDP-17 or related tauopathies.</p></div><div id="mdel17q21_31.Differential_Diagnosis"><h2 id="_mdel17q21_31_Differential_Diagnosis_">Differential Diagnosis</h2><p>The most common findings in Koolen-de Vries syndrome (KdVS), developmental delay and childhood hypotonia, are common and relatively nonspecific indications for molecular <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> analysis. However, the concurrent finding of characteristic facial <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features, epilepsy, hypermetropia, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects, renal or urologic anomalies, cryptorchidism, and/or friendly/amiable behavior may prompt specific consideration of the diagnosis of Koolen-de Vries syndrome. See <a class="figpopup" href="/books/NBK24676/table/mdel17q21_31.T.disorders_with_developmen/?report=objectonly" target="object" rid-figpopup="figmdel17q2131Tdisorderswithdevelopmen" rid-ob="figobmdel17q2131Tdisorderswithdevelopmen">Table 3</a> for other diagnoses with developmental delay and intellectual disability that may be considered in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><div id="mdel17q21_31.T.disorders_with_developmen" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders with Developmental Delay and Intellectual Disability to Consider in the Differential Diagnosis of Koolen-de Vries Syndrome (KdVS)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.disorders_with_developmen/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.disorders_with_developmen_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene / Genetic<br />Mechanism</th><th id="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4" id="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Additional features overlapping w/KdVS</th><th headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4" id="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from KdVS</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gr_22q11deletion/">Deletion 22q11.2</a>&#x000a0;<sup>1</sup><br />(velocardiofacial syndrome)</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Long face, narrow palpebral fissures, prominent tubular nose w/bulbous nasal tip</div></li><li class="half_rhythm"><div>Ventricular septal defects</div></li><li class="half_rhythm"><div>Slender hands &#x00026; digits</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal hypocalcemia</div></li><li class="half_rhythm"><div>T-lymphocyte dysfunction</div></li><li class="half_rhythm"><div>Epilepsy less common</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pws/">Prader-Willi syndrome</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormal parent-specific <a class="def" href="/books/n/gene/glossary/def-item/imprinting/">imprinting</a> w/in Prader-Willi <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Severe neonatal/childhood hypotonia</div></li><li class="half_rhythm"><div>Seizures</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Upslanting palpebral fissures</div></li><li class="half_rhythm"><div>Cryptorchidism</div></li><li class="half_rhythm"><div>Blonde to light brown hair</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Childhood hyperphagia</div></li><li class="half_rhythm"><div>Central obesity</div></li><li class="half_rhythm"><div>Behavior problems &#x00026; sleep disturbances more common than in KdVS</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fragilex/">Fragile X syndrome</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Genetic alteration in <i>FMR1</i></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Facial gestalt (adult males w/KdVS may show some coarsening &#x00026; elongation w/&#x02191; age)</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overactivity, impulsivity, &#x00026; challenging behavior more common</td></tr><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/angelman/">Angelman syndrome</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disruption of maternally <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <i>UBE3A</i></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 4</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Speech &#x00026; language delay</div></li><li class="half_rhythm"><div>Feeding problems &#x00026;/or muscle hypotonia in infancy</div></li><li class="half_rhythm"><div>Epilepsy</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Microcephaly &#x00026; seizures common</div></li><li class="half_rhythm"><div>Gait ataxia &#x00026;/or tremulous limbs</div></li><li class="half_rhythm"><div>Inappropriate happy demeanor</div></li><li class="half_rhythm"><div>More marked &#x00026; persistent speech delay beyond preschool years (rarely phrase-level speech)&#x000a0;<sup>5</sup></div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cfc/">Cardiofaciocutaneous syndrome</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BRAF</i>&#x000a0;<sup>6</sup><br /><i>MAP2K1</i><br /><i>MAP2K2</i><br /><i>KRAS</i></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Nevi &#x00026; other pigmentary skin abnormalities</div></li><li class="half_rhythm"><div>Congenital heart anomalies</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Postnatal short stature</div></li><li class="half_rhythm"><div>Coarse facies; fine &#x00026; brittle hair</div></li><li class="half_rhythm"><div>Cardiac abnormalities more frequent</div></li></ul>
</td></tr><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/wac-id/">WAC-related ID</a></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>WAC</i></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal/childhood hypotonia</div></li><li class="half_rhythm"><div>Language &#x00026; motor DD</div></li><li class="half_rhythm"><div>Congenital abnormalities of urogenital system</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Epilepsy less common</td></tr><tr><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Say-Barber-Biesecker variant of Ohdo syndrome (see <a href="/books/n/gene/kat6b-dis/"><i>KAT6B</i>-Related Disorders</a>)</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KAT6B</i></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>2</sup></td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neonatal hypotonia &#x00026; feeding difficulties</div></li><li class="half_rhythm"><div>Blepharophimosis; bulbous nose</div></li><li class="half_rhythm"><div>Cryptorchidism</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_1_4 hd_h_mdel17q21_31.T.disorders_with_developmen_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Immobile mask-like face</div></li><li class="half_rhythm"><div>Patellar hypoplasia/agenesis</div></li><li class="half_rhythm"><div>Lacrimal duct anomalies</div></li><li class="half_rhythm"><div>Hearing loss</div></li><li class="half_rhythm"><div>Thyroid anomalies</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; DD = developmental delay; ID = intellectual disability; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="mdel17q21_31.TF.3.1"><p class="no_margin">KdVS may be considered in individuals who tested negative for <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 22q11.2.</p></div></dd><dt>2. </dt><dd><div id="mdel17q21_31.TF.3.2"><p class="no_margin">Typically <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a></p></div></dd><dt>3. </dt><dd><div id="mdel17q21_31.TF.3.3"><p class="no_margin">The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with PWS depends on the genetic mechanism that resulted in the absence of expression of the paternally contributed 15q11.2-q13 region.</p></div></dd><dt>4. </dt><dd><div id="mdel17q21_31.TF.3.4"><p class="no_margin">The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with Angelman syndrome depends on the genetic mechanism leading to the loss of <i>UBE3A</i> function.</p></div></dd><dt>5. </dt><dd><div id="mdel17q21_31.TF.3.5"><p class="no_margin">Research shows that prognosis for speech in individuals with KdVS is positive; apraxia resolves, and although dysarthria persists, most children are intelligible by mid-to-late childhood [<a class="bk_pop" href="#mdel17q21_31.REF.morgan.2018a.75">Morgan et al 2018a</a>]. Speech delay in children with Angelman syndrome remains far more severe [<a class="bk_pop" href="#mdel17q21_31.REF.grieco.2018.e49">Grieco et al 2018</a>], however, there is little published information on communication in individuals with Angelman syndrome.</p></div></dd><dt>6. </dt><dd><div id="mdel17q21_31.TF.3.6"><p class="no_margin">75% of individuals with cardiofaciocutaneous syndrome have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>BRAF</i>. Three other genes known to be associated with CFC syndrome are: <i>MAP2K1</i> and <i>MAP2K2</i> (~25%), and <i>KRAS</i> (&#x0003c;2%).</p></div></dd></dl></div></div></div></div><div id="mdel17q21_31.Management"><h2 id="_mdel17q21_31_Management_">Management</h2><div id="mdel17q21_31.Evaluations_Following_Initi"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the clinical consequences in an individual diagnosed with Koolen-de Vries syndrome (KdVS), the following evaluations are recommended if they have not already been completed.</p><div id="mdel17q21_31.T.recommended_evaluations_f" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of Koolen-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.recommended_evaluations_f/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.recommended_evaluations_f_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><br />System/Concern</th><th id="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of growth parameters to identify those w/failure to thrive</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider investigation of growth hormone deficiency in individuals w/short stature.</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology evaluation</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT/Mouth</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiologic examination</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac evaluation</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For possible heart anomalies incl septal defects &#x00026; aortic dilatation</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding assessment</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Asses for sucking &#x00026; swallowing difficulties &#x00026; need for feeding therapy in infancy.</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Renal ultrasound examination</div></li><li class="half_rhythm"><div>Voiding cystourethrogram, if indicated</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for ureteral reflux &#x00026; other renal problems.</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To incl motor, speech/language evaluation, general cognitive, &#x00026; vocational skills</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric evaluation</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Screen for behavior concerns incl sleep disturbances, ADHD, anxiety, &#x00026;/or traits suggestive of ASD.</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Brain imaging studies in individuals w/microcephaly &#x00026;/or seizure</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consideration of a Chiari malformation type 1 in those w/suggestive symptoms (headache, neck pain, cerebellar signs, or muscle weakness)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">EEG if seizures are suspected</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to neurologist for seizure disorder management</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_mdel17q21_31.T.recommended_evaluations_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADHD = attention-deficit/hyperactivity disorder; ASD = autism spectrum disorder</p></div></dd><dt>1. </dt><dd><div id="mdel17q21_31.TF.4.1"><p class="no_margin"><a class="bk_pop" href="#mdel17q21_31.REF.terrone.2012.466">Terrone et al [2012]</a></p></div></dd></dl></div></div></div></div><div id="mdel17q21_31.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment includes routine medical care by a pediatrician or other primary physician and the following.</p><div id="mdel17q21_31.T.treatment_of_manifestatio" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Koolen-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.treatment_of_manifestatio/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.treatment_of_manifestatio_lrgtbl__"><table><thead><tr><th id="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/<br />Concern</th><th id="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding problems &#x00026; motor delay related to hypotonia</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early intervention / feeding therapy / physiotherapy</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nasogastric tube feeding may be required for neonates w/severe feeding issues.</td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Vision issues / strabismus</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard management for visual problems as directed by ophthalmologist</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hearing loss</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard management</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac, renal, urologic, &#x00026; other medical issues</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard management of specific issue</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cryptorchidism</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment by urologist, if indicated</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment / routine antiepileptic drugs under care of neurologist</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech &#x00026; language</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Speech production requires intensive motor speech treatment in preschool yrs.</div></li><li class="half_rhythm"><div>Language development requires focused intervention &#x00026; augmentative (sign language) or alternative (communication device) support until oral speech &#x00026; language develops.</div></li><li class="half_rhythm"><div>Feeding abilities &#x02013; support development of chewing.</div></li><li class="half_rhythm"><div>Early sound awareness to support literacy development</div></li><li class="half_rhythm"><div>In older children, work on social skill development.</div></li></ul>
</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis / Hip dislocation / Positional deformities of the feet</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard orthopedic care</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Multiple nevi</b></td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Regular checkup by dermatologist if multiple nevi present</td><td headers="hd_h_mdel17q21_31.T.treatment_of_manifestatio_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States (US); standard recommendations may vary from country to country.</p><div id="mdel17q21_31.Developmental_Disability__I"><h4>Developmental Disability / Intellectual Disability Management Issues</h4><p>Children with KdVS require early, intensive speech motor and language therapy, with targeted literacy and social language interventions as developmentally appropriate.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual&#x02019;s level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="mdel17q21_31.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility and to reduce the risk for later-onset orthopedic complications (e.g., contractures, scoliosis, hip dislocation).</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy &#x02013; typically from an occupational or speech therapist &#x02013; is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) used alongside verbal therapies for individuals who have expressive language difficulties. Intensive verbal speech therapy approaches for childhood apraxia of speech are recommended in the early years [<a class="bk_pop" href="#mdel17q21_31.REF.morgan.2018b.cd006278">Morgan et al 2018b</a>] and literacy, dysarthria, and social skill therapies are required in the school years.</p></div><div id="mdel17q21_31.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child&#x02019;s behavioral, social, and adaptive strengths and weaknesses and is typically performed one-on-one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications when necessary.</p></div></div><div id="mdel17q21_31.Surveillance"><h3>Surveillance</h3><div id="mdel17q21_31.T.recommended_surveillance" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Koolen-de Vries Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.recommended_surveillance/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.recommended_surveillance_lrgtbl__"><table><thead><tr><th id="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ongoing pediatric care</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmology evaluation due to &#x02191; risk for hypermetropia &#x00026; strabismus</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine intervals</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring as needed</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring as needed</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring for spine deformities/scoliosis</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Routine intervals until growth is complete</td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Specialized neurologic care for individuals w/epilepsy</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellanous/</b><br /><b>Other</b></td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor developmental progress &#x00026; educational needs</td><td headers="hd_h_mdel17q21_31.T.recommended_surveillance_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="mdel17q21_31.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#mdel17q21_31.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mdel17q21_31.Therapies_Under_Investigati"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="mdel17q21_31.Genetic_Counseling"><h2 id="_mdel17q21_31_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mdel17q21_31.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Koolen-de Vries syndrome (KdVS), caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 17q21.31 or a heterozygous intragenic <i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single affected individual in the family).</p></div><div id="mdel17q21_31.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, all reported intragenic <i>KANSL1</i> pathogenic variants and almost all reported 17q21.31 deletions have been <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a><i>.</i></div></li><li class="half_rhythm"><div>Evaluation of the parents by testing that will detect the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or intragenic <i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> present in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended. <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis in the parents to evaluate for a balanced <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> and/or translocations may also be considered. Note: Testing for the 17q21.31 inversion <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> is not recommended (see <a href="#mdel17q21_31.Molecular_Genetics">Molecular Genetics</a>).</div></li><li class="half_rhythm"><div>If the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or intragenic <i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be identified in the leukocyte DNA of either parent, the most likely explanation is that the genetic alteration is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. Another possible explanation is <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> and/or somatic and <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Somatic and (presumed) germline mosaicism for a 17q21.31 deletion has been identified in at least two parents [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012a.729">Koolen et al 2012a</a>].</div></li><li class="half_rhythm"><div>Theoretically, a parent could have a balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement involving 17q21.31 resulting in a 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child; balanced chromosome rearrangements in parents involving 17q21.31 have not been reported to date.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If the parents are clinically unaffected, the risk to sibs is low (probably &#x0003c;1%) but greater than that of the general population because the parents may have one of the following:</div><ul><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012a.729">Koolen et al 2012a</a>]</div></li><li class="half_rhythm"><div>A balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement involving 17q21.31 (not reported, but theoretically possible)</div></li></ul></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals who have the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or a <i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the genetic alteration to each child.</div></li><li class="half_rhythm"><div>To date, one individual diagnosed with KdVS has been known to reproduce [Author, personal observation].</div></li></ul><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has a KdVS-related genetic alteration or, theoretically, a balanced chromosomal rearrangement, his or her family members may be at risk.</p></div><div id="mdel17q21_31.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of a child with KdVS.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mdel17q21_31.Prenatal_Testing_and_Preimp"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the KdVS-related genetic alteration has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="mdel17q21_31.Resources"><h2 id="_mdel17q21_31_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Kool Kid Alliance</b></div><div>P.O. Box 928</div><div>Arden NC 28704</div><div><a href="https://www.koolkidalliance.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.koolkidalliance.com</a></div></li><li class="half_rhythm"><div><b>Supporting Families with Koolen-de Vries Syndrome</b></div><div><i>Enriching lives through education, awareness and research.</i></div><div>P.O. Box 470218</div><div>Fort Worth TX 76147</div><div><b>Phone:</b> 833-721-KDVS</div><div><a href="https://supportingkdvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.supportingkdvs.org</a></div></li><li class="half_rhythm"><div><b>Chromosome Disorder Outreach (CDO)</b></div><div>PO Box 724</div><div>Boca Raton FL 33429-0724</div><div><b>Phone:</b> 561-395-4252 (Family Helpline)</div><div><b>Email:</b> info@chromodisorder.org</div><div><a href="http://www.chromodisorder.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chromodisorder.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Koolen-De%20Vries%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Koolen-De Vries syndrome</a></div></li><li class="half_rhythm"><div><b>Unique: The Rare Chromosome Disorder Support Group</b></div><div>G1 The Stables</div><div>Station Road West</div><div>Oxted Surrey RH8 9EE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 1883 723356</div><div><b>Email:</b> info@rarechromo.org; rarechromo@aol.com</div><div><a href="http://www.rarechromo.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarechromo.org</a></div></li><li class="half_rhythm"><div><b>GenIDA Registry: Genetically determined Intellectual Disabilities and Autism Spectrum Disorders</b></div><div><i>A website for Patients, Families and Professionals</i></div><div>France</div><div><a href="https://genida.unistra.fr/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GenIDA</a></div></li><li class="half_rhythm"><div><b>Human Disease Gene Website Series - Registry</b></div><div><b>Email:</b> info@humandiseasegenes.com</div><div><a href="https://humandiseasegenes.nl/hdgw/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Koolen-de Vries syndrome</a></div></li></ul></div><div id="mdel17q21_31.Molecular_Genetics"><h2 id="_mdel17q21_31_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mdel17q21_31.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Koolen-de Vries Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mdel17q21_31.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mdel17q21_31.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mdel17q21_31.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mdel17q21_31.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_mdel17q21_31.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mdel17q21_31.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/284058" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>KANSL1</i></a></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=284058" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q21<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7Z3B3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KAT8 regulatory NSL complex subunit 1</a></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/KANSL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KANSL1 @ LOVD</a></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=KANSL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KANSL1</a></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=KANSL1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">KANSL1</a></td></tr><tr><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><i>Not applicable</i></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">17q21.31</td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_mdel17q21_31.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mdel17q21_31.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mdel17q21_31.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Koolen-de Vries Syndrome (<a href="/omim/610443,612452" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610443" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610443</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KOOLEN-DE VRIES SYNDROME; KDVS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612452" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612452</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">KAT8 REGULATORY NSL COMPLEX, SUBUNIT 1; KANSL1</td></tr></tbody></table></div></div><div id="mdel17q21_31.17q21_31_Deletion"><h3>17q21.31 Deletion</h3><p>The 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is typically 500 to 650 kb in size (hg19: chr17:43,700,000-44,250,000) and is flanked by segmental duplications that mediate <a class="def" href="/books/n/gene/glossary/def-item/nonallelic-homologous-recombination/">nonallelic homologous recombination</a> [<a class="bk_pop" href="#mdel17q21_31.REF.itsara.2012.599">Itsara et al 2012</a>]. Genetic testing of the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> region is challenging. The mapping and interpretation of the deletion breakpoints are confounded by the structural complexity and genomic variation of the 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>]. Two haplotypes exist, in direct (H1) and inverted (H2) orientation [<a class="bk_pop" href="#mdel17q21_31.REF.stefansson.2005.129">Stefansson et al 2005</a>]. The H2 haplotype is enriched in Europeans, and carriers are predisposed to the 17q21.31 microdeletion [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2006.999">Koolen et al 2006</a>, <a class="bk_pop" href="#mdel17q21_31.REF.sharp.2006.1038">Sharp et al 2006</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2008.710">Koolen et al 2008</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zody.2008.1076">Zody et al 2008</a>]. The frequency of <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> 17q21.31 microdeletions in carriers of the H2 inversion is low, and other as-yet poorly understood factors are likely to be important in the generation of the deletion.</p><p>Besides the recurrent classic 17q21.31 microdeletion, several atypical 17q21.31 deletions have been described in children with clinical features typically associated with the classic 17q21.31 microdeletion [<a class="bk_pop" href="#mdel17q21_31.REF.cooper.2011.838">Cooper et al 2011</a>, <a class="bk_pop" href="#mdel17q21_31.REF.dubourg.2011.144">Dubourg et al 2011</a>, <a class="bk_pop" href="#mdel17q21_31.REF.kitsioutzeli.2012.319">Kitsiou-Tzeli et al 2012</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>]. All these atypical deletions encompass at least <i>KANSL1</i>. Moreover, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants were identified in children with clinical features that are in keeping with the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> seen in individuals with a classic 17q21.31 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, showing that <i>KANSL1</i> is actually the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> involved in this <a class="def" href="/books/n/gene/glossary/def-item/microdeletion-syndrome/">microdeletion syndrome</a> [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2012.636">Zollino et al 2012</a>].</p></div><div id="mdel17q21_31.KANSL1"><h3><i>KANSL1</i></h3><p><b>Gene structure.</b>
<i>KANSL1</i> has several transcript variants. The longest, <a href="/nuccore/NM_001193466.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001193466.1</a>, has 15 exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcript, and protein information see <a href="/books/NBK24676/#mdel17q21_31.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, all pathogenic <i>KANSL1</i> variants reported are truncating variants. [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2012.636">Zollino et al 2012</a>, <a class="bk_pop" href="#mdel17q21_31.REF.zollino.2015.804">Zollino et al 2015</a>, <a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>].</p><div id="mdel17q21_31.T.selected_kansl1_pathogeni" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Selected <i>KANSL1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK24676/table/mdel17q21_31.T.selected_kansl1_pathogeni/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mdel17q21_31.T.selected_kansl1_pathogeni_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.916C&#x0003e;T</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln306Ter</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_001193466.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001193466<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/NP_001180395.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001180395<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1816C&#x0003e;T</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg606Ter</td></tr><tr><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1652+1G&#x0003e;A</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td></tr><tr><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2785_2786delAG</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg929GlyfsTer44</td></tr><tr><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1867_1870del</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile623AlafsTer6</td></tr><tr><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.985_986del</td><td headers="hd_h_mdel17q21_31.T.selected_kansl1_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu329GlufsTer22</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="mdel17q21_31.TF.7.1"><p class="no_margin">Splice-site variant resulting in skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6, causing a frameshift and premature termination of the <i>KANSL1</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2012b.639">Koolen et al 2012b</a>]</p></div></dd></dl></div></div></div><p>The 17q21.31 inversion <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> (H2 haplotype) and the copy number polymorphism clusters encompassing exons 1&#x02013;3 of KANSL1 contribute to difficulties in SNV calling, such as <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant "artefacts" in <i>KANSL1</i> [<a class="bk_pop" href="#mdel17q21_31.REF.koolen.2016.652">Koolen et al 2016</a>]. The detection of a truncating variant in exons 1-3 of <i>KANSL1</i> is not sufficient to make a diagnosis of KdVS. In these cases, next to a compatible clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, variant analysis of the parental samples is of the utmost importance to verify that the possibly <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>KANSL1</i> encodes KAT8 regulatory NSL complex subunit 1, the longer isoform of which (<a href="/protein/NP_001180395.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001180395.1</a>) has 1,105 amino acids. KANSL1 is a scaffold protein of the nonspecific lethal complex that contains the histone acetyltransferase MOF, which acetylates histone H4 on lysine 16 (H4K16ac) to facilitate transcriptional activation [<a class="bk_pop" href="#mdel17q21_31.REF.mendjan.2006.811">Mendjan et al 2006</a>].</p><p>H4K16ac activates the expression of a broad set of genes including several autophagy-related genes [<a class="bk_pop" href="#mdel17q21_31.REF.f_llgrabe.2013.1621">F&#x000fc;llgrabe et al 2013</a>]. Autophagy is a catabolic process important for the clearance of protein aggregates and damaged organelles within the cell, which is essential for cell homeostasis and survival. Autophagy is essential in neurons, not only for cell homeostasis but also for regulation of development and function [<a class="bk_pop" href="#mdel17q21_31.REF.shehata.2012.10413">Shehata et al 2012</a>, <a class="bk_pop" href="#mdel17q21_31.REF.tang.2014.276">Tang et al 2014</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Studies in mice have shown that <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> loss of <i>Kansl1</i> leads to changes in gene expression related to synaptic transmission and to a decrease in basal synaptic transmission and plasticity [<a class="bk_pop" href="#mdel17q21_31.REF.arbogast.2017.e1006886">Arbogast et al 2017</a>], but the underlying cellular mechanisms remain unknown. H4K16ac is known to be essential for the regulation of autophagy, a process controlling degradation and recycling of proteins and shown to play a role in synapse development and function. Disruption in autophagy can therefore lead to impairments in neuronal development and synaptic transmission and could play an essential role in the pathophysiology of KdVS.</p></div></div><div id="mdel17q21_31.References"><h2 id="_mdel17q21_31_References_">References</h2><div id="mdel17q21_31.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.arbogast.2017.e1006886">Arbogast T, Iacono G, Chevalier C, Afinowi NO, Houbaert X, van Eede MC, Laliberte C, Birling MC, Linda K, Meziane H, Selloum M, Sorg T, Nadif Kasri N, Koolen DA, Stunnenberg HG, Henkelman RM, Kopanitsa M, Humeau Y, De Vries BBA, Herault Y. Mouse models of 17q21.31 microdeletion and microduplication syndromes highlight the importance of Kansl1 for cognition. <span><span class="ref-journal">PLoS Genet. </span>2017;<span class="ref-vol">13</span>:e1006886.</span> [<a href="/pmc/articles/PMC5531616/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5531616</span></a>] [<a href="/pubmed/28704368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28704368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.cooper.2011.838">Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, Williams C, Stalker H, Hamid R, Hannig V, Abdel-Hamid H, Bader P, McCracken E, Niyazov D, Leppig K, Thiese H, Hummel M, Alexander N, Gorski J, Kussmann J, Shashi V, Johnson K, Rehder C, Ballif BC, Shaffer LG, Eichler EE. A copy number variation morbidity map of developmental delay. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:838–46.</span> [<a href="/pmc/articles/PMC3171215/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3171215</span></a>] [<a href="/pubmed/21841781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21841781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.dubourg.2011.144">Dubourg C, Sanlaville D, Doco-Fenzy M, Le Caignec C, Missirian C, Jaillard S, Schluth-Bolard C, Landais E, Boute O, Philip N, Toutain A, David A, Edery P, Moncla A, Martin-Coignard D, Vincent-Delorme C, Mortemousque I, Duban-Bedu B, Drunat S, Beri M, Mosser J, Odent S, David V, Andrieux J. Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation. <span><span class="ref-journal">Eur J Med Genet. </span>2011;<span class="ref-vol">54</span>:144–51.</span> [<a href="/pubmed/21094706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21094706</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.el_chehadehdjebbar.2011.369">El Chehadeh-Djebbar S, Callier P, Masurel-Paulet A, Bensignor C, M&#x000e9;jean N, Payet M, Ragon C, Durand C, Marle N, Mosca-Boidron AL, Huet F, Mugneret F, Faivre L, Thauvin-Robinet C. 17q21.31 microdeletion in a patient with pituitary stalk interruption syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2011;<span class="ref-vol">54</span>:369–73.</span> [<a href="/pubmed/21397059" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21397059</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.f_llgrabe.2013.1621">F&#x000fc;llgrabe J, Lynch-Day MA, Heldring N, Li W, Struijk RB, Ma Q, Hermanson O, Rosenfeld MG, Klionsky DJ, Joseph B. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. <span><span class="ref-journal">Autophagy. </span>2013;<span class="ref-vol">9</span>:1621–3.</span> [<a href="/pmc/articles/PMC4006103/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4006103</span></a>] [<a href="/pubmed/23863932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23863932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.grieco.2018.e49">Grieco JC, Bahr RH, Schoenberg MR, Conover L, Mackie LN, Weeber EJ. Quantitative measurement of communication ability in children with Angelman syndrome. <span><span class="ref-journal">J Appl Res Intellect Disabil. </span>2018;<span class="ref-vol">31</span>:e49–e58.</span> [<a href="/pubmed/27990716" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27990716</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.grisart.2009.524">Grisart B, Willatt L, Destr&#x000e9;e A, Fryns JP, Rack K, de Ravel T, Rosenfeld J, Vermeesch JR, Verellen-Dumoulin C, Sandford R. 17q21.31 microduplication patients are characterised by behavioural problems and poor social interaction. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:524–30.</span> [<a href="/pubmed/19502243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19502243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.itsara.2012.599">Itsara A, Vissers LE, Steinberg KM, Meyer KJ, Zody MC, Koolen DA, de Ligt J, Cuppen E, Baker C, Lee C, Graves TA, Wilson RK, Jenkins RB, Veltman JA, Eichler EE. Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencing. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:599–613.</span> [<a href="/pmc/articles/PMC3322237/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3322237</span></a>] [<a href="/pubmed/22482802" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22482802</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.kirchhoff.2007.256">Kirchhoff M, Bisgaard AM, Duno M, Hansen FJ, Schwartz M. A. 17q21.31 microduplication, reciprocal to the newly described 17q21.31 microdeletion, in a girl with severe psychomotor developmental delay and dysmorphic craniofacial features. <span><span class="ref-journal">Eur J Med Genet. </span>2007;<span class="ref-vol">50</span>:256–63.</span> [<a href="/pubmed/17576104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17576104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.kitsioutzeli.2012.319">Kitsiou-Tzeli S, Frysira H, Giannikou K, Syrmou A, Kosma K, Kakourou G, Leze E, Sofocleous C, Kanavakis E, Tzetis M. Microdeletion and microduplication 17q21.31 plus an additional CNV, in patients with intellectual disability, identified by array-CGH. <span><span class="ref-journal">Gene. </span>2012;<span class="ref-vol">492</span>:319–24.</span> [<a href="/pubmed/22037486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22037486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.koolen.2012a.729">Koolen DA, Dupont J, de Leeuw N, Vissers LE, van den Heuvel SP, Bradbury A, Steer J, de Brouwer AP, Ten Kate LP, Nillesen WM, de Vries BB, Parker MJ. Two families with sibling recurrence of the 17q21.31 microdeletion syndrome due to low-grade mosaicism. <span><span class="ref-journal">Eur J Hum Genet. </span>2012a;<span class="ref-vol">20</span>:729–33.</span> [<a href="/pmc/articles/PMC3376266/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3376266</span></a>] [<a href="/pubmed/22293690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22293690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.koolen.2012b.639">Koolen DA, Kramer JM, Neveling K, Nillesen WM, Moore-Barton HL, Elmslie FV, Toutain A, Amiel J, Malan V, Tsai AC, Cheung SW, Gilissen C, Verwiel ET, Martens S, Feuth T, Bongers EM, de Vries P, Scheffer H, Vissers LE, de Brouwer AP, Brunner HG, Veltman JA, Schenck A, Yntema HG, de Vries BB. Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. <span><span class="ref-journal">Nat Genet. </span>2012b;<span class="ref-vol">44</span>:639–41.</span> [<a href="/pubmed/22544363" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22544363</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.koolen.2016.652">Koolen DA, Pfundt R, Linda K, Beunders G, Veenstra-Knol HE, Conta JH, Fortuna AM, Gillessen-Kaesbach G, Dugan S, Halbach S, Abdul-Rahman OA, Winesett HM, Chung WK, Dalton M, Dimova PS, Mattina T, Prescott K, Zhang HZ, Saal HM, Hehir-Kwa JY, Willemsen MH, Ockeloen CW, Jongmans MC, Van der Aa N, Failla P, Barone C, Avola E, Brooks AS, Kant SG, Gerkes EH, Firth HV, &#x000d5;unap K, Bird LM, Masser-Frye D, Friedman JR, Sokunbi MA, Dixit A, Splitt M, Study DDD, Kukolich MK, McGaughran J, Coe BP, Fl&#x000f3;rez J, Nadif Kasri N, Brunner HG, Thompson EM, Gecz J, Romano C, Eichler EE, de Vries BB. The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:652–9.</span> [<a href="/pmc/articles/PMC4930086/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4930086</span></a>] [<a href="/pubmed/26306646" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26306646</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.koolen.2008.710">Koolen DA, Sharp AJ, Hurst JA, Firth HV, Knight SJ, Goldenberg A, Saugier-Veber P, Pfundt R, Vissers LE, Destr&#x000e9;e A, Grisart B, Rooms L, Van der Aa N, Field M, Hackett A, Bell K, Nowaczyk MJ, Mancini GM, Poddighe PJ, Schwartz CE, Rossi E, De Gregori M, Antonacci-Fulton LL, McLellan MD 2nd, Garrett JM, Wiechert MA, Miner TL, Crosby S, Ciccone R, Willatt L, Rauch A, Zenker M, Aradhya S, Manning MA, Strom TM, Wagenstaller J, Krepischi-Santos AC, Vianna-Morgante AM, Rosenberg C, Price SM, Stewart H, Shaw-Smith C, Brunner HG, Wilkie AO, Veltman JA, Zuffardi O, Eichler EE, de Vries BB. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. <span><span class="ref-journal">J Med Genet. </span>2008;<span class="ref-vol">45</span>:710–20.</span> [<a href="/pmc/articles/PMC3071570/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3071570</span></a>] [<a href="/pubmed/18628315" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18628315</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.koolen.2006.999">Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, Regan R, Kooy RF, Reyniers E, Romano C, Fichera M, Schinzel A, Baumer A, Anderlid BM, Schoumans J, Knoers NV, van Kessel AG, Sistermans EA, Veltman JA, Brunner HG, de Vries BB. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:999–1001.</span> [<a href="/pubmed/16906164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16906164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.mendjan.2006.811">Mendjan S, Taipale M, Kind J, Holz H, Gebhardt P, Schelder M, Vermeulen M, Buscaino A, Duncan K, Mueller J, Wilm M, Stunnenberg HG, Saumweber H, Akhtar A. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. <span><span class="ref-journal">Mol Cell. </span>2006;<span class="ref-vol">21</span>:811–23.</span> [<a href="/pubmed/16543150" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16543150</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.morenoigoa.2015.68">Moreno-Igoa M, Hern&#x000e1;ndez-Charro B, Bengoa-Alonso A, P&#x000e9;rez-Juana-del-Casal A, Romero-Ibarra C, Nieva-Echebarria B, Ramos-Arroyo MA. KANSL1 gene disruption associated with the full clinical spectrum of 17q21.31 microdeletion syndrome. <span><span class="ref-journal">BMC Med Genet. </span>2015;<span class="ref-vol">16</span>:68.</span> [<a href="/pmc/articles/PMC4593202/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4593202</span></a>] [<a href="/pubmed/26293599" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26293599</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.morgan.2018a.75">Morgan AT, Haaften LV, van Hulst K, Edley C, Mei C, Tan TY, Amor D, Fisher SE, Koolen DA. Early speech development in Koolen de Vries syndrome limited by oral praxis and hypotonia. <span><span class="ref-journal">Eur J Hum Genet. </span>2018a;<span class="ref-vol">26</span>:75–84.</span> [<a href="/pmc/articles/PMC5839037/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5839037</span></a>] [<a href="/pubmed/29225339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29225339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.morgan.2018b.cd006278">Morgan AT, Murray E, Li&#x000e9;geois FJ. Interventions for childhood apraxia of speech. <span><span class="ref-journal">Cochrane Database Syst Rev. </span>2018b;<span class="ref-vol">5</span>:CD006278.</span> [<a href="/pmc/articles/PMC6494637/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6494637</span></a>] [<a href="/pubmed/29845607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29845607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.myers.2017.1085">Myers KA, Mandelstam SA, Ramantani G, Rushing EJ, de Vries BB, Koolen DA, Scheffer IE. The epileptology of Koolen-de Vries syndrome: electro-clinico-radiologic findings in 31 patients. <span><span class="ref-journal">Epilepsia. </span>2017;<span class="ref-vol">58</span>:1085–94.</span> [<a href="/pubmed/28440867" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28440867</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.sharp.2006.1038">Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, Hurst JA, Stewart H, Price SM, Blair E, Hennekam RC, Fitzpatrick CA, Segraves R, Richmond TA, Guiver C, Albertson DG, Pinkel D, Eis PS, Schwartz S, Knight SJ, Eichler EE. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:1038–42.</span> [<a href="/pubmed/16906162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16906162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.shawsmith.2006.1032">Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, Porter K, Prigmore E, Krepischi-Santos AC, Varela MC, Koiffmann CP, Lees AJ, Rosenberg C, Firth HV, de Silva R, Carter NP. Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:1032–7.</span> [<a href="/pubmed/16906163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16906163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.shehata.2012.10413">Shehata M, Matsumura H, Okubo-Suzuki R, Ohkawa N, Inokuchi K. Neuronal stimulation induces autophagy in hippocampal neurons that is involved in AMPA receptor degradation after chemical long-term depression. <span><span class="ref-journal">J Neurosci. </span>2012;<span class="ref-vol">32</span>:10413–22.</span> [<a href="/pmc/articles/PMC6703735/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6703735</span></a>] [<a href="/pubmed/22836274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22836274</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.stefansson.2005.129">Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G, Barnard J, Baker A, Jonasdottir A, Ingason A, Gudnadottir VG, Desnica N, Hicks A, Gylfason A, Gudbjartsson DF, Jonsdottir GM, Sainz J, Agnarsson K, Birgisdottir B, Ghosh S, Olafsdottir A, Cazier JB, Kristjansson K, Frigge ML, Thorgeirsson TE, Gulcher JR, Kong A, Stefansson K. A common inversion under selection in Europeans. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:129–37.</span> [<a href="/pubmed/15654335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15654335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.tan.2009.480">Tan TY, Aftimos S, Worgan L, Susman R, Wilson M, Ghedia S, Kirk EP, Love D, Ronan A, Darmanian A, Slavotinek A, Hogue J, Moeschler JB, Ozmore J, Widmer R, Bruno D, Savarirayan R, Peters G. Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:480–9.</span> [<a href="/pubmed/19447831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19447831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.tang.2014.276">Tang P, Hou H, Zhang L, Lan X, Mao Z, Liu D, He C, Du H, Zhang L. Autophagy reduces neuronal damage and promotes locomotor recovery via inhibition of apoptosis after spinal cord injury in rats. <span><span class="ref-journal">Mol Neurobiol. </span>2014;<span class="ref-vol">49</span>:276–87.</span> [<a href="/pubmed/23954967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23954967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.terrone.2012.466">Terrone G, D'Amico A, Imperati F, Carella M, Palumbo O, Gentile M, Canani RB, Melis D, Romano A, Parente I, Riccitelli M, Del Giudice E. A further contribution to the delineation of the 17q21.31 microdeletion syndrome: central nervous involvement in two Italian patients. <span><span class="ref-journal">Eur J Med Genet. </span>2012;<span class="ref-vol">55</span>:466–71.</span> [<a href="/pubmed/22659270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22659270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.wright.2011.15">Wright EB, Donnai D, Johnson D, Clayton-Smith J. Cutaneous features in 17q21.31 deletion syndrome: a differential diagnosis for cardio-facio-cutaneous syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2011;<span class="ref-vol">20</span>:15–20.</span> [<a href="/pmc/articles/PMC3000393/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3000393</span></a>] [<a href="/pubmed/21084979" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21084979</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.zody.2008.1076">Zody MC, Jiang Z, Fung HC, Antonacci F, Hillier LW, Cardone MF, Graves TA, Kidd JM, Cheng Z, Abouelleil A, Chen L, Wallis J, Glasscock J, Wilson RK, Reily AD, Duckworth J, Ventura M, Hardy J, Warren WC, Eichler EE. Evolutionary toggling of the MAPT 17q21.31 inversion region. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1076–83.</span> [<a href="/pmc/articles/PMC2684794/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2684794</span></a>] [<a href="/pubmed/19165922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19165922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.zollino.2012.636">Zollino M, Orteschi D, Murdolo M, Lattante S, Battaglia D, Stefanini C, Mercuri E, Chiurazzi P, Neri G, Marangi G. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:636–8.</span> [<a href="/pubmed/22544367" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22544367</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mdel17q21_31.REF.zollino.2015.804">Zollino M, Marangi G, Ponzi E, Orteschi D, Ricciardi S, Lattante S, Murdolo M, Battaglia D, Contaldo I, Mercuri E, Stefanini MC, Caumes R, Edery P, Rossi M, Piccione M, Corsello G, Della Monica M, Scarano F, Priolo M, Gentile M, Zampino G, Vijzelaar R, Abdulrahman O, Rauch A, Oneda B, Deardorff MA, Saitta SC, Falk MJ, Dubbs H, Zackai E. Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:804–14.</span> [<a href="/pubmed/26424144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26424144</span></a>]</div></li></ul></div></div><div id="mdel17q21_31.Chapter_Notes"><h2 id="_mdel17q21_31_Chapter_Notes_">Chapter Notes</h2><div id="mdel17q21_31.Author_Notes"><h3>Author Notes</h3><p>Radboudumc Center of Expertise Rare Congenital Developmental Disorders <a href="https://www.radboudumc.nl/en/expertise-centers/rare-congenital-developmental-disorders" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Website</a></p></div><div id="mdel17q21_31.Acknowledgments"><h3>Acknowledgments</h3><p>The authors gratefully acknowledge the members of 17q21.31 microdeletion support groups and other parents for their participation in research and for their generous sharing of information.</p></div><div id="mdel17q21_31.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 June 2019 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 January 2013 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>KANSL1</i> available clinically</div></li><li class="half_rhythm"><div>20 November 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 January 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>28 August 2009 (dak) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK24676</span><span class="label">PMID: <a href="/pubmed/20301783" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301783</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/kleefstra/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/krabbe/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK24676&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK24676/?report=reader">PubReader</a></li><li><a href="/books/NBK24676/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK24676" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK24676" style="display:none" title="Cite this Page"><div class="bk_tt">Koolen DA, Morgan A, de Vries BBA. Koolen-de Vries Syndrome. 2010 Jan 26 [Updated 2019 Jun 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK24676/pdf/Bookshelf_NBK24676.pdf">PDF version of this page</a> (628K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mdel17q21_31.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mdel17q21_31.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mdel17q21_31.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mdel17q21_31.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mdel17q21_31.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mdel17q21_31.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mdel17q21_31.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mdel17q21_31.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mdel17q21_31.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mdel17q21_31.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mdel17q21_31.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=284058[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KANSL1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK24676+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1949014" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1949014" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1949014" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1949014" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26306646" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant.</a><span class="source">[Eur J Hum Genet. 2016]</span><div class="brieflinkpop offscreen_noflow">The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Koolen DA, Pfundt R, Linda K, Beunders G, Veenstra-Knol HE, Conta JH, Fortuna AM, Gillessen-Kaesbach G, Dugan S, Halbach S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Hum Genet. 2016 May; 24(5):652-9. Epub 2015 Aug 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145572" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gabriele-de Vries Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gabriele-de Vries Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nabais Sá MJ, Gabriele M, Testa G, de Vries BBA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28440867" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients.</a><span class="source">[Epilepsia. 2017]</span><div class="brieflinkpop offscreen_noflow">The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Myers KA, Mandelstam SA, Ramantani G, Rushing EJ, de Vries BB, Koolen DA, Scheffer IE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Epilepsia. 2017 Jun; 58(6):1085-1094. Epub 2017 Apr 25.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28211987" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">10-year-old female with intragenic KANSL1 mutation, no KANSL1-related intellectual disability, and preserved verbal intelligence.</a><span class="source">[Am J Med Genet A. 2017]</span><div class="brieflinkpop offscreen_noflow">10-year-old female with intragenic KANSL1 mutation, no KANSL1-related intellectual disability, and preserved verbal intelligence.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Keen C, Samango-Sprouse C, Dubbs H, Zackai EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet A. 2017 Mar; 173(3):762-765. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20945554" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kleefstra Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Kleefstra Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kleefstra T, de Leeuw N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301783" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301783" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b57dd21425a25cc61c9">Koolen-de Vries Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Koolen-de Vries Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:39:03-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BC17EE0414EC1000000000A1C03E3&amp;ncbi_session=CE8BC17EE042B561_2588SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK24676%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK24676&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK24676/&amp;ncbi_pagename=Koolen-de Vries Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BC17EE042B561_2588SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>